Protective effect of diazoxide against antimycin A-induced mitochondrial dysfunction in osteoblastic MC3T3-E1 cells

Toxicology in Vitro

Volumn 25, Issue 8, 2011, Pages 1603-1608

  Choi, Eun Mi ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Diazoxide; Mitochondrial dysfunction; Osteoblastic MC3T3 E1 cells

Indexed keywords

3 NITROTYROSINE; ADENOSINE TRIPHOSPHATE; ANTIMYCIN A1; CALCIUM; CYTOCHROME C OXIDASE; DIAZOXIDE; SUPEROXIDE; THIOREDOXIN REDUCTASE; UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL FUNCTION; CELL LOSS; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; ELECTRON TRANSPORT; ENZYME ACTIVATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OSTEOBLAST;

ANIMALS; ANTIMYCIN A; CALCIUM; CELL LINE; CELL SURVIVAL; DIAZOXIDE; ELECTRON TRANSPORT COMPLEX IV; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; OSTEOBLASTS; OXIDATIVE STRESS; PROTECTIVE AGENTS; SUPEROXIDES; THIOREDOXIN-DISULFIDE REDUCTASE; TYROSINE;

EID: 82655174007     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.06.004     Document Type: Article

References (38)

1. Akao M., Ohler A., O'Rourke B., Marban E. Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ. Res. 2001, 88:1267-1275.
2. Atamna H. Heme, iron, and the mitochondrial decay of ageing. Ageing Res. Rev. 2004, 3(3):303-318.
3. Blomgren K., Leist M., Groc L. Pathological apoptosis in the developing brain. Apoptosis 2007, 12:993-1010.
4. Brouillet E., Jenkins B.G., Hyman B.T., Ferrante R.J., Kowall N.W., Srivastava R., Roy D.S., Rosen B.R., Beal M.F. Age dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropioni acid. J. Neurochem. 1993, 60:356-359.
5. Cadenas E. Mitochondrial free radical production and cell signaling. Mol. Aspects Med. 2004, 25:17-26.
6. Cai J., Jones D.P. Mitochondrial redox signaling during apoptosis. J. Bioenergy. Biomembr. 1999, 31:327-334.
7. Clementi E., Brown G.C., Foxwell N., Moncada S. On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc. Natl. Acad. Sci. USA 1999, 96:1559-1562.
8. Cooper C., Melton L.J.I. Magnitude and impact of osteoporosis and fractures. Osteoporosis 1996, 419-434. Academic Press, San Diego. J. Kelsey (Ed.).
9. Fiskum G., Rosenthal R.E., Vereczki V., Martin E., Hoffman G.E., Chinopoulos C., Kowaltowski A. Protection against ischemic brain injury by inhibition of mitochondrial oxidative stress. J. Bioenergy. Biomembr. 2004, 36:347-352.
10. Formigli L., Papucci L., Tani A., Schiavone N., Tempestini A., Orlandini G.E., Capaccioli S., ZecchiOrlandini S. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J. Cell. Physiol. 2000, 182:41-49.
11. Fryer R.M., Eells J.T., Hsu A.K., Henry M.M., Gross G.J. Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H305-H312.
12. Guthrie H.D., Welch G.R. Determination of high mitochondrial membrane potential in spermatozoa loaded with the mitochondrial probe 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolyl-carbocyanine iodide (JC-1) by using fluorescence-activated flow cytometry. Methods Mol. Biol. 2008, 477:89-97.
13. Hargreaves I.P., Duncan A.J., Wu L., Agrawal A., Land J.M., Heales S.J. Inhibition of mitochondrial complex IV leads to secondary loss complex II-III activity: implications for the pathogenesis and treatment of mitochondrial encephalomyopathies. Mitochondrion 2007, 7(4):284-287.
14. Higashi T., Isomoto A., Tyuma I., Kakishita E., Uomoto M., Nagai K. Quantitative and continuous analysis of ATP release from blood platelets with firefly luciferase luminescence. Thromb. Haemost. 1985, 53(1):65-69.
15. Kaur H., Halliwell B. Evidence for nitric-oxide-mediated oxidative damage in chronic inflammation: nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 1994, 350:9-12.
16. Kirby D.M., Thorburn D.R., Turnbull D.M., Taylor R.W. Biochemical assays of respiratory chain complex activity. Methods Cell Biol. 2007, 80:93-119.
17. ATP channel opener diazoxide protects cardiac myocytes during metabolic inhibition without causing mitochondrial depolarization or flavoprotein oxidation. Br. J. Pharmacol. 2001, 134:535-542.
18. 2 within the hydrophobic interior of biological membranes. J. Biol. Chem. 1998, 273:18709-18713.
19. McBride H.M., Neuspiel M., Wasiak S. Mitochondria: more than just a powerhouse. Curr. Biol. 2006, 16:R551-R560.
20. Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
21. Mustacich D., Powis G. Thioredoxin reductase. Biochem. J. 2000, 346:1-8.
22. Myers J.M., Myers C.R. The effects of hexavelant chromium on thioredoxin reductase and peroxiredoxins in human bronchial epithelial cells. Free Radic. Biol. Med. 2009, 47:1477-1485.
23. Navarro A., Boveris A. The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 2007, 292:C670-C686.
24. Navarro A., López-Cepero J.M., Bández M.J., Sánchez-Pino M.J., Gómez C., Cadenas E., Boveris A. Hippocampal mitochondrial dysfunction in rat aging. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294(2):R501-R509.
25. ATP channel induces early and delayed cardioprotective effect: role of nitric oxide. Am. J. Physiol. 1999, 277:H2425-H2434.
26. Poderoso J.J., Lisdero C., Schopfer F., Riobo N., Carreras M.C., Cadenas E., Boveris A. The regulation of mitochondrial oxygen uptake by redoxreactions involving nitric oxide and ubiquinol. J. Biol. Chem. 1999, 274:37709-37716.
27. Quarles L.D., Yohay D.A., Lever L.W., Caton R., Wenstrup R.J. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J. Bone Miner. Res. 1992, 7:683-690.
28. Shake J.G., Peck E.A., Marban E., Gott V.L., Johnston M.V., Troncoso J.C., Redmond J.M., Baumgartner W.A. Pharmacologically induced preconditioning with diazoxide: a novel approach to brain protection. Ann. Thorac. Surg. 2001, 72:1849-1854.
29. Shimizu S., Eguchi Y., Kamiike W., Waguri S., Uchiyama Y., Matsuda H., Tsujimoto Y. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene 1996, 12:2045-2050.
30. Shiva S., Brookes P.S., Patel R.P., Anderson P.G., Darley-Usmar V.M. Nitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase. Proc. Natl. Acad. Sci. USA 2001, 98:7212-7217.
31. Simbula G., Glascott P.A., Akita S., Hoek J.B., Farber J.L. Two mechanisms by which ATP depletion potentiates induction of the mitochondrial permeability transition. Am. J. Physiol. 1997, 273:C479-C488.
32. Smith T.S., Bennett J.P.J.R. Mitochondrial toxins in neurodegenerative diseases: In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions. Brain Res. 1997, 765:183-186.
33. Steenbergen C., Murphy E., Watts J.A., London R.E. Correlation between cytosolic free calcium, contracture, ATP and irreversible ischemic injury in perfused rat heart. Circ. Res. 1990, 66:135-146.
34. Wang Z., Wang Y., Hegg E.L. Regulation of the hemeA biosynthetic pathway: differential regulation of heme A synthase and heme O synthase in Saccharomyces cerevisiae. J. Biol. Chem. 2009, 284(2):839-847.
35. 2+ homeostasis in cardiomyocytes. Mol. Cell. Biochem. 1997, 172(1-2):149-157.
36. Yamawaki H., Haendeler J., Berk B.C. Thioredoxin: a key regulator of cardiovascular homeostasis. Circ. Res. 2003, 93:1029-1033.
37. Zhang M., Mileykovskaya E., Dowhan W. Cardiolipin is essential for organization of complexes III and IV into a supercomplex in intact yeast mitochondria. J. Biol. Chem. 2005, 280(33):29403-29408.
38. Zielonka J., Kalyanaraman B. Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth. Free Radic. Biol. Med. 2010, 48(8):983-1001.